Effects of dietary fruits, vegetables and a herbal tea on the in vitro transport of cimetidine: Comparing the Caco-2 model with porcine jejunum tissue

Pharmaceutical Biology

Volumn 50, Issue 2, 2012, Pages 254-263

  Tarirai, Clemence ^a   Viljoen, Alvaro M ^a   Hamman, Josias H ^a  

^a TSHWANE UNIVERSITY OF TECHNOLOGY   (South Africa)

Author keywords

Caco 2; Efflux; Pharmacokinetic interactions; Pig intestinal tissue; Plant extracts

Indexed keywords

CIMETIDINE; PLANT EXTRACT; VERAPAMIL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; DIETARY INTAKE; DRUG BIOAVAILABILITY; DRUG POTENTIATION; DRUG TRANSPORT; FRUIT; HERB DRUG INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; JEJUNUM; NONHUMAN; SWINE; TEA; VEGETABLE;

ANIMALS; BEVERAGES; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CIMETIDINE; DIETARY SUPPLEMENTS; FOOD-DRUG INTERACTIONS; FRUIT; HUMANS; INTESTINAL ABSORPTION; JEJUNUM; PLANT EXTRACTS; SWINE; VEGETABLES; VERAPAMIL;

AMARANTHACEAE; ANACARDIACEAE; APIACEAE; ASPALATHUS LINEARIS; BETA VULGARIS; DAUCUS CAROTA; DOVYALIS CAFFRA; FABACEAE; FLACOURTIACEAE; FRAGARIA X ANANASSA; MYRTACEAE; PRUNUS DOMESTICA; PRUNUS PERSICA; PSIDIUM; PSIDIUM GUAJAVA; ROSACEAE; SCLEROCARYA BIRREA; SUIDAE; SUS;

EID: 84855802620     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2011.598169     Document Type: Article

References (33)

1. Artursson P, Palm K, Luthman K. (2001). Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev, 46, 27-43
2. Bansal T, Mishra G, Jaggi M, Khar RK, Talegaonkar S. (2009). Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats. Eur j Pharm Sci, 36, 580-590
3. Colalto C. (2010). Herbal interactions on absorption of drugs: Mechanisms of action and clinical risk assessment. Pharmacol Res, 62, 207-227
4. Collett A, Higgs NB, Sims E, Rowland M, Warhurst G. (1999). Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2. J Pharmacol Exp Ther, 288, 171-178 (Pubitemid 29113488)
5. Döppenschmitt S, Spahn-Langguth H, Regårdh CG, Langguth P. (1999). Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein. J Pharm Sci, 88, 1067-1072 (Pubitemid 29480601)
6. Dudley AJ, Brown CD. (1996). Mediation of cimetidine secretion by P-glycoprotein and a novel H(+)-coupled mechanism in cultured renal epithelial monolayers of LLC-PK1 cells. Br J Pharmacol, 117, 1139-1144
7. Elsby R, Surry DD, Smith VN, Gray AJ. (2008). Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions. Xenobiotica, 38, 1140-1164
8. Farkas D, Greenblatt DJ. (2008). Influence of fruit juices on drug disposition: Discrepancies between in vitro and clinical studies. Expert Opin Drug Metab Toxicol, 4, 381-393 (Pubitemid 351728513)
9. Gutíérrez RMP, Mitchell S, Solis RV. (2008). Psidium guajava: A review of its traditional uses, phytochemistry and pharmacology. J Ethnophamacol, 117, 1-27
10. Hansen TS, Nilsen OG. (2009). Echinacea purpurea and P-glycoprotein drug transport in Caco-2 cells. Phytother Res, 23, 86-91
11. Harris RZ, Jang GR, Tsunoda S. (2003). Dietary effects on drug metabolism and transport. Clin Pharmacokinet, 42, 1071-1088 (Pubitemid 37357646)
12. Hayeshi R, Masimirembwa C, Mukanganyama S, Ungell AL. (2006). The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux. Eur J Pharm Sci, 29, 70-81 (Pubitemid 44294861)
13. Hsiu SL, Hou YC, Wang YH, Tsao CW, Su SF, Chao PD. (2002). Quercetin significantly decreased cyclosporin oral bioavailability in pigs and rats. Life Sci, 72, 227-235
14. Ingersoll RE. (2005). Herbaceuticals: An overview for counselors. J Counsel Dev, 83, 434-443 (Pubitemid 41639137)
15. Jantratid E, Prakongpan S, Dressman JB, Amidon GL, Junginger HE, Midha KK, Barends DM. (2006). Biowaiver monographs for immediate release solid oral dosage forms: cimetidine. J Pharm Sci, 95, 974-984 (Pubitemid 43723158)
16. Katragadda S, Budda B, Anand BS, Mitra AK. (2005). Role of efflux pumps and metabolising enzymes in drug delivery. Expert Opin Drug Deliv, 2, 683-705 (Pubitemid 41038680)
17. Laffont CM, De Vrieze G, Maas R, Bousquet-Mélou A, Fink-Gremmels J. (2003). Comparative evaluation of p-gp activity in cattle, sheep, goats, pigs, horses, and rats using a limphocyte-based ex vivo model. J Vet Pharm Therap, 26, 82-307
18. Legen I, Salobir M, Kerc J. (2005). Comparison of different intestinal epithelia as models for absorption enhancement studies. Int J Pharm, 291, 183-188 (Pubitemid 40222010)
19. Mandava N, Oberol RK, Minocha M, Mitra AK. (2010). Transporter targeted drug delivery. J Drug Deliv Sci Technol, 20, 89-99
20. Neirinckx E, Vervaet C, Michiels J, De Smet S, Van den Broeck W, Remon JP, De Backer P, Croubels S. (2011). Feasibility of the Ussing chamber technique for the determination of in vitro jejunal permeability of passively absorbed compounds in different animal species. J Vet Pharmacol Ther, 34, 290-297
21. Rubas W, Jezyk N, Grass GM. (1993). Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption. Pharm Res, 10, 113-118 (Pubitemid 23020847)
22. Schwarz UI, Seemann D, Oertel R, Miehlke S, Kuhlisch E, Fromm MF, Kim RB, Bailey DG, Kirch W. (2005). Grapefruit juice ingestion significantly reduces talinolol bioavailability. Clin Pharmacol Ther, 77, 291-301 (Pubitemid 40470385)
23. Sica DA. (2006). Interaction of grapefruit juice and calcium channel blockers. Am J Hypertens, 19, 768-773 (Pubitemid 43928515)
24. Spahn-Langguth H, Langguth P. (2001). Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol. Eur J Pharm Sci, 12, 361-367 (Pubitemid 32166734)
25. Sukhai M, Piquette-Miller M. (2000). Regulation of the multidrug resistance genes by stress signals. J Pharm Pharm Sci, 3, 268-280
26. Sun J, He ZG, Cheng G, Wang SJ, Hao XH, Zou MJ. (2004). Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction. Med Sci Monit, 10, RA5-R14
27. Takagi T, Ramachandran C, Bermejo M, Yamashita S, Yu LX, Amidon GL. (2006). A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. Mol Pharm, 3, 631-643 (Pubitemid 46087480)
28. Tang H, Pak Y, Mayersohn M. (2004). Protein expression pattern of P-glycoprotein along the gastrointestinal tract of the Yucatan micropig. J Biochem Mol Toxicol, 18, 18-22 (Pubitemid 38312718)
29. Tarirai C, Viljoen AM, Hamman JH. (2010). Herb-drug pharmacokinetic interactions reviewed. Expert Opin Drug Metab Toxicol, 6, 1515-1538
30. Taur JS, Rodriguez-Proteau R. (2008). Effects of dietary flavonoids on the transport of cimetidine via P-glycoprotein and cationic transporters in Caco-2 and LLC-PK1 cell models. Xenobiotica, 38, 1536-1550
31. Varma MV, Ashokraj Y, Dey CS, Panchagnula R. (2003). P-glycoprotein inhibitors and their screening: A perspective from bioavailability enhancement. Pharmacol Res, 48, 347-359 (Pubitemid 36945333)
32. Varma MV, Perumal OP, Panchagnula R. (2006). Functional role of P-glycoprotein in limiting peroral drug absorption: optimizing drug delivery. Curr Opin Chem Biol, 10, 367-373 (Pubitemid 44080650)
33. Viljoen AM, Kamatou GPP, Basér KHC. (2008). Head-space volatiles of marula (Sclerocarya birrea subsp. caffra). S Afr J Bot, 74, 325-326 (Pubitemid 351484152)